Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015054
Filing Date
2025-05-30
Accepted
2025-05-30 19:26:39
Documents
1
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 form4-05302025_110528.html 4  
1 form4-05302025_110528.xml 4 4087
  Complete submission text file 0001415889-25-015054.txt   5608
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Kassberg Thomas Richard (Reporting) CIK: 0001303811 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 251012779

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)